Sodium-Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome

• Главные авторы: Fernando Cortés-Camacho (Автор), Oscar René Zambrano-Vásquez (Автор), Elena Aréchaga-Ocampo (Автор), Jorge Ismael Castañeda-Sánchez (Автор), José Guillermo Gonzaga-Sánchez (Автор), José Luis Sánchez-Gloria (Автор), Laura Gabriela Sánchez-Lozada (Автор), Horacio Osorio-Alonso (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2024-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Metabolic syndrome (MetS) is a multifactorial condition that significantly increases the risk of cardiovascular disease and chronic kidney disease (CKD). Recent studies have emphasized the role of lipid dysregulation in activating cellular mechanisms that contribute to CKD progression in the context...